Aug 12, 2015Cellectar Biosciences Announces 2nd Quarter Financial Results
Aug 7, 2015Cellectar Biosciences to Host Conference Call on August 12th to Discuss Second Quarter Financial Results and Provide Update on Development Plans
Cellectar’s product candidates are built on a novel, cancer and cancer stem cell-targeting delivery and retention platform of optimized phospholipid ether analogs (PLEs). We have shown that PLEs become trapped in malignant tumor cell membranes because tumor cells cannot metabolize and eliminate them.
The Annual Meeting of Stockholders of Cellectar Biosciences, Inc. will be held on Thursday, May 28, 2015 at 10:00 A.M., local time, at its headquarters at 3301 Agriculture Drive, Madison, WI 53716
CLRB Corporate Presentation 2015 (pdf)